EMILY RENEE WATSON: Open Payments
NPI 1811323710 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,454 in 51 payments from 14 companies in 2025. Trend: 2023 $2,023 · 2024 $1,258 · 2025 $1,454
Food & beverage: $1,382Education: $72
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $407 |
| Janssen Biotech, Inc. | 14 | $339 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $160 |
| UCB, Inc. | 5 | $107 |
| GENZYME CORPORATION | 3 | $94 |
| Lilly USA, LLC | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| Biofrontera Inc. | 2 | $53 |
| LEO Pharma Inc. | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $29 |
Products named: Winlevi, TREMFYA, DUPIXENT, Cabtreo, Bimzelx, TALTZ, ADBRY, JUBLIA.
Industry payments across CA — which companies pay providers there.
